Apple Inc. (AAPL) Is A Good Stock for 2013, Inc. (NASDAQ:AMZN), despite good revenue growth and numerous business prospects, remains a very low profits company and analyst consensus for 2013 implies a forward P/E of 148. Buying simply doesn’t make sense at that price, given how large the company is and how much time it has had to convert its sales into net income, and it may even be a short candidate. Then there’s Research in Motion Limited (NASDAQ:RIMM), which has seen a strong rally in its stock price as it appears that its new Blackberry model may actually be a strong offering in the modern smartphone market. That seems like a speculative reason to buy, however, and with net losses expected for the fiscal year ending in February 2014 as well as the current one there just isn’t a value case there yet.

We aren’t as optimistic as the sell-side on Apple’s future earnings; however, the company doesn’t have to even come close to their estimates in order to prove undervalued. Even modest growth- and we feel fairly comfortable counting on that- should carry the stock higher from its current levels.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!